Sudden sensorineural hearing loss (SSNHL) affects an estimated 5 to 20 people per 100,000 population each year worldwide. Based on Australia's current population of roughly 27 million, that translates to between 1,350 and 5,400 new Australian cases annually. Yet many people who experience rapid hearing loss delay seeking help, assuming the problem is a blocked ear or a passing issue. That delay can cost them their hearing. Unlike most forms of hearing loss that develop gradually over years, sudden hearing loss strikes without warning and demands immediate action. This article explains what sudden hearing loss is, what causes it, why the first 48 hours are critical, and what treatments give the best chance of recovery.
What Is Sudden Hearing Loss
Clinicians define sudden sensorineural hearing loss as a hearing reduction of at least 30 decibels across three consecutive frequencies, occurring within a 72-hour period. In practical terms, that means a person wakes up one morning, or notices over the course of a single day, that one ear has gone significantly deaf. The loss typically affects one ear only, though bilateral cases do occur rarely. Many patients also report tinnitus (ringing or buzzing in the affected ear), a feeling of fullness or pressure, and sometimes vertigo or dizziness.
It is important to distinguish SSNHL from conductive hearing loss, which involves a mechanical problem in the ear canal or middle ear. Earwax impaction, fluid behind the eardrum, and eardrum perforation can all cause rapid hearing reduction but are not SSNHL and require different management. A doctor or audiologist can determine the type of loss through examination and audiometric testing. This distinction matters because sudden sensorineural hearing loss is an inner ear problem that carries a risk of permanent damage if not treated promptly.
The condition is also referred to as sudden deafness. It can happen at any age but peaks between 50 and 60 years. Men and women are affected at roughly equal rates. The hearing loss may be partial or profound, and the audiometric pattern varies: some people lose high frequencies, others lose low frequencies, and some experience a flat loss across all frequencies. The pattern and severity of the loss are among the factors that influence recovery outcomes.
Common Causes of Sudden Hearing Loss
In roughly 70 to 90 per cent of cases, no definitive cause is identified. These cases are classified as idiopathic sudden sensorineural hearing loss. When a cause can be determined, it typically falls into one of several categories.
Viral Infections
Viral infections are among the most commonly identified triggers. Viruses that cause upper respiratory infections, influenza, herpes simplex, cytomegalovirus, and mumps have all been linked to SSNHL. The proposed mechanism involves either direct viral invasion of the cochlea or a secondary inflammatory response that damages the delicate structures of the inner ear. Some patients report a recent cold or flu in the days before their hearing dropped, though the connection is not always apparent.
Vascular Issues
The cochlea receives its blood supply from a single artery, the labyrinthine artery, with virtually no collateral circulation. A disruption to this blood supply, whether through a small clot, spasm, or haemorrhage, can deprive the inner ear of oxygen and nutrients. This vascular vulnerability is one reason SSNHL shares risk factors with cardiovascular disease, including hypertension, diabetes, hyperlipidaemia, and smoking. Vascular compromise is considered more likely in older patients and those with existing cardiovascular conditions.
Autoimmune Conditions
Autoimmune inner ear disease occurs when the body's immune system mistakenly attacks the structures of the cochlea. This can present as sudden hearing loss, sometimes in both ears, and may be associated with systemic autoimmune conditions such as lupus, rheumatoid arthritis, or Cogan syndrome. Autoimmune hearing loss often responds to steroid treatment but may require longer-term immunosuppressive therapy to prevent recurrence.
Other Identified Causes
Less common causes include acoustic neuroma (a benign tumour on the hearing nerve), Meniere disease, perilymph fistula (a leak of inner ear fluid), trauma to the head or ear, ototoxic medications, and neurological conditions such as multiple sclerosis. Lyme disease and syphilis are rare infectious causes. In each case, identifying the underlying condition is important because it changes the treatment approach and prognosis.
Why the 48-Hour Window Matters
Time is the single most important variable in sudden hearing loss treatment. The inner ear is extraordinarily sensitive to injury, and the window for reversing damage closes quickly. Research consistently shows that patients who begin treatment within 48 to 72 hours of onset have significantly better recovery outcomes than those who wait. The American Academy of Otolaryngology Head and Neck Surgery (AAO-HNS) clinical practice guideline, updated in 2019, recommends initiating corticosteroid therapy as soon as possible, noting that the likelihood of meaningful recovery declines substantially after the first two weeks.
The biological reason is straightforward. When the cochlea is injured, whether by inflammation, reduced blood flow, or viral damage, the affected hair cells and nerve fibres begin to deteriorate. Steroids reduce inflammation and oedema, potentially preserving cells that would otherwise die. But once those cells have been without adequate oxygen or nutrients for too long, the damage becomes irreversible. The cochlea has approximately 15,000 hair cells, and they do not regenerate in humans. Every hour of delayed treatment increases the proportion of cells that pass the point of no return.
This is why clinicians treat sudden hearing loss as an otological emergency. If you experience rapid hearing loss in one or both ears, the correct response is not to wait and see. The correct response is to seek medical evaluation the same day. A comprehensive hearing test can confirm the type and degree of loss, and a physician can initiate treatment immediately. In Melbourne, several hospital emergency departments and ENT clinics accept urgent referrals for suspected SSNHL.
Sudden Hearing Loss Treatment Options
Treatment for SSNHL aims to reduce inflammation, improve circulation to the cochlea, and preserve the remaining hair cells and neural structures. Several treatment approaches are used, often in combination.
Oral Corticosteroids
Oral corticosteroids, typically prednisone or prednisolone at a dose of 1 mg per kilogram of body weight per day for 10 to 14 days with a tapering schedule, are the standard first-line treatment for SSNHL. The AAO-HNS guideline gives this a strong recommendation based on evidence from randomised controlled trials. Oral steroids work by suppressing the inflammatory response in the cochlea and are most effective when started within the first week of symptom onset. Common side effects include elevated blood sugar, mood changes, insomnia, and gastrointestinal irritation, though the short treatment duration limits these effects in most patients.
Intratympanic Steroid Injections
When oral steroids are contraindicated (for example, in patients with poorly controlled diabetes) or have failed to produce adequate recovery, steroids can be delivered directly into the middle ear through the eardrum. This technique, called intratympanic injection, delivers a much higher concentration of the drug to the inner ear while minimising systemic side effects. The procedure is performed in a clinic by an ENT specialist, typically using dexamethasone or methylprednisolone. Multiple injections may be given over several weeks. The AAO-HNS guideline offers intratympanic steroids as a salvage treatment option, and growing evidence supports their use as primary therapy in selected patients.
Hyperbaric Oxygen Therapy
Hyperbaric oxygen therapy (HBOT) involves breathing pure oxygen in a pressurised chamber, which increases the amount of dissolved oxygen in the blood and improves oxygen delivery to oxygen-starved tissues, including the cochlea. The AAO-HNS guideline conditionally recommends HBOT as an adjunct to steroids when initiated within two weeks of onset. A Cochrane review found that patients treated with HBOT in addition to steroids were more likely to achieve complete or partial hearing recovery compared with steroids alone. However, HBOT is not widely available, requires multiple sessions (typically 10 to 20), and is not suitable for all patients.
Additional Therapies
When a specific cause is identified, additional treatments target the underlying condition. Antiviral medications may be prescribed when a viral aetiology is suspected. Immunosuppressive drugs are used for autoimmune cases. Anticoagulants or vasodilators are sometimes prescribed when vascular compromise is suspected, though evidence for these is limited. Patients with suspected perilymph fistula may be advised to rest and avoid straining, with surgical repair in some cases. The treatment plan is always individualised based on the patient's history, examination findings, and audiometric results.
Recovery Rates and What to Expect
Recovery from sudden hearing loss varies widely and depends on several factors. Without any treatment, spontaneous recovery occurs in roughly 32 to 65 per cent of patients, with milder losses recovering more often than profound ones. With prompt steroid treatment, recovery rates improve substantially. Studies report that 50 to 80 per cent of treated patients achieve some degree of recovery, though the definition of recovery varies across studies and not all recovery is complete.
Several prognostic factors influence outcomes. Patients with mild to moderate initial losses tend to recover better than those with profound or total deafness. Younger age is associated with better outcomes. The absence of vertigo is a positive sign. Down-sloping and mid-frequency audiometric patterns carry a better prognosis than flat or total losses. Most importantly, early treatment consistently predicts better recovery across virtually all published studies.
Recovery typically occurs within the first two to four weeks after treatment begins, though some patients continue to improve over several months. Hearing may return to normal, return partially, or not return at all. For patients with residual hearing loss, hearing aids, and in severe cases cochlear implants, can provide significant benefit. An audiologist can guide rehabilitation based on the degree and pattern of remaining loss.
Follow-up audiometry is essential to track recovery. Most clinicians repeat hearing tests at the end of the steroid course, then again at one month and three months. These results inform decisions about salvage therapy, hearing aid fitting, and whether further investigation is needed to rule out an underlying cause such as acoustic neuroma. A Melbourne audiologist can coordinate this ongoing monitoring and adjust the management plan as your hearing changes.
When to Seek Urgent Help
Any sudden change in hearing warrants same-day medical attention. This applies whether the loss is partial or complete, whether it affects one ear or both, and whether it is accompanied by other symptoms or occurs in isolation. The key word is sudden. If your hearing drops noticeably over the course of hours or a few days, treat it as urgent.
Your first point of contact can be your GP, a hospital emergency department, or an audiologist. A GP or emergency doctor can rule out conductive causes and refer you to an ENT specialist for steroid treatment. An audiologist can perform immediate testing to confirm the degree and type of loss, which is critical information for the treating physician. If you are in Melbourne, you can visit one of our clinics for same-day hearing assessment when sudden loss is suspected.
Do not wait to see if the hearing returns on its own. Do not assume it is just earwax or fluid from a cold. While those are possible explanations, the consequences of missing a window to treat sudden sensorineural hearing loss are permanent. A single hearing test takes roughly 30 minutes and can make the difference between recovery and lasting deafness.
Frequently Asked Questions
Can sudden hearing loss recover without treatment?
Some cases of sudden sensorineural hearing loss recover partially or fully without treatment. Research suggests that spontaneous recovery occurs in roughly 32 to 65 per cent of patients, particularly those with mild to moderate losses. However, recovery rates are significantly higher with prompt steroid treatment, and delaying treatment reduces the chances of full recovery. Medical evaluation should never be postponed in the hope that hearing will return on its own.
How quickly should sudden hearing loss be treated?
Sudden hearing loss should be evaluated by a doctor or audiologist as soon as possible, ideally within 48 hours of onset. The American Academy of Otolaryngology clinical practice guideline recommends initiating corticosteroid treatment within two weeks, but outcomes are best when treatment begins within the first 48 to 72 hours. The longer the delay, the lower the probability of meaningful hearing recovery.
Is sudden hearing loss in one ear a medical emergency?
Yes, sudden hearing loss in one ear is considered an otological emergency that requires urgent medical assessment. While it may be caused by something as simple as earwax blockage, it can also indicate sudden sensorineural hearing loss, which involves permanent damage to the inner ear. Because the treatment window is narrow, anyone experiencing rapid hearing loss in one ear should seek medical attention the same day.
What tests are used to diagnose sudden hearing loss?
Diagnosis begins with a physical examination of the ear canal and eardrum to rule out obstructions or infection. A pure-tone audiometry test measures hearing thresholds across frequencies and confirms the degree of loss. Tympanometry assesses middle ear function. Speech audiometry evaluates how well speech is understood. In some cases, an MRI scan may be ordered to rule out acoustic neuroma or other structural causes. Blood tests may also be used to check for autoimmune or inflammatory markers.
Works Cited
Chandrasekhar, Sujana S., et al. "Clinical Practice Guideline: Sudden Hearing Loss (Update)." Otolaryngology Head and Neck Surgery, vol. 161, no. 1 suppl, 2019, pp. 1S-45S.
Kuhn, Mark, et al. "Sudden Sensorineural Hearing Loss: A Review of Diagnosis, Treatment, and Prognosis." Trends in Amplification, vol. 15, no. 3, 2011, pp. 91-105.
Bennett, Matthew H., et al. "Hyperbaric Oxygen Therapy for Idiopathic Sudden Sensorineural Hearing Loss and Tinnitus: A Systematic Review of Randomised Controlled Trials." Cochrane Database of Systematic Reviews, no. 10, 2012, Art. No. CD004739.
Wei, Bi Pu, et al. "The Incidence of Sudden Sensorineural Hearing Loss in the United States." Otolaryngology Head and Neck Surgery, vol. 163, no. 4, 2020, pp. 702-707.
Australian Institute of Health and Welfare. "Ear and Hearing Health." AIHW, Australian Government, 2024, aihw.gov.au/reports/australias-health/hearing-health.
Hearing Australia. "Sudden Hearing Loss: Information and Guidance." Australian Government, 2024, hearing.com.au.
Stachler, Robert J., et al. "Clinical Practice Guideline: Sudden Hearing Loss." Otolaryngology Head and Neck Surgery, vol. 146, no. 3 suppl, 2012, pp. 1S-35S.